IOL Chemicals and Pharmaceuticals Ltd Stock Price Today (NSE: IOLCP)

IOL Chemicals and Pharmaceuticals Ltd

125.100.96 (0.76%)
Market Open

Fundamental Score

...

IOL Chemicals and Pharmaceuticals Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

IOL Chemicals and Pharmaceuticals Ltd share price today is 125.10, down 0.76% on NSE/BSE as of 17 June 2026. IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of 2.64K (Cr). The 52-week high for IOLCP share price is 138.90 and the 52-week low is 67.19. At a P/E ratio of 22.72x, IOLCP is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 6.13% and a debt-to-equity ratio of 0.09.

IOL Chemicals and Pharmaceuticals Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
138.90
Low
90.00
Volume
58.6L
Change
+42.53%

IOL Chemicals and Pharmaceuticals Ltd share price chart: 42.53% return over the past month. 52-week high ₹138.90, 52-week low ₹67.19.

IOL Chemicals and Pharmaceuticals Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
124.98132.00123.97131.4226.96L (Cr)
130.00135.03121.55125.8739.05L (Cr)
131.90132.92128.02128.9828.25L (Cr)
131.40131.40131.40131.400.00 (Cr)
136.65137.59130.00131.4045.42L (Cr)
124.95138.90124.94136.06191.47L (Cr)
119.21126.00119.21124.0064.02L (Cr)
121.05124.40118.21118.7358.29L (Cr)
118.81126.72114.47121.17176.47L (Cr)
109.00121.40107.01119.54210.91L (Cr)

IOL Chemicals and Pharmaceuticals Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
130.00135.03121.55131.42+1.09%
94.32138.9094.10128.98+36.75%
75.5097.7973.8194.32+24.93%
71.2580.3967.1972.77+2.13%
73.0083.4070.2073.05+0.07%
83.0084.8567.9874.03-10.81%
90.2391.3479.0782.26-8.83%
92.59101.8087.9190.04-2.75%
103.10108.3892.0092.53-10.25%
91.18126.6691.18102.78+12.72%
103.00103.3488.6490.74-11.90%
97.88106.0089.83103.16+5.39%

Returns & Performance

Poor

Return on Equity (ROE)

6.13%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

8.86%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

14.28%

Average operating profit margin over 5 years

Dividend Yield

0.89%

Annual dividend as % of current share price

IOL Chemicals and Pharmaceuticals Ltd Valuation Check

Good

Price to Earnings (P/E)

22.72x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.77x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

52.62%

% shares held by company founders/management

Poor

FII Holding

2.25%

% shares held by foreign institutional investors

Poor

DII Holding

0.05%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

56.66%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

7.95%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

1.88%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-22.97%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-22.48%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.09x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

10.80x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

110.31 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

IOL Chemicals and Pharmaceuticals Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of IOLCP across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Attractive Valuation (P/E: 22.72 vs Industry: 31.77)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (56.66%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Conservative Debt Levels (D/E: 0.09)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (10.80x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Cash Generation (₹110.31 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (52.62%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

6 factors identified

Below-Average Return on Equity (6.13%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (8.86%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Limited Growth History (1.88% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Earnings Growth (-22.97% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-22.48% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Limited Institutional Interest (FII+DII: 2.30%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

IOL Chemicals and Pharmaceuticals Ltd vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare IOL Chemicals and Pharmaceuticals Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
42.1/100
125
₹2638.81
22.7
Average
6.13%
Poor
8.86%
Poor
0.1
Excellent
-22.48%
Poor
1.88%
Average
0.89%
65.2/100
1844
₹433738.68
37.6
Average
16.86%
Good
20.21%
Excellent
0.1
Excellent
23.78%
Excellent
9.87%
Good
0.89%
67.9/100
6798
₹170445.88
68.6
Average
15.35%
Good
20.44%
Excellent
0.0
Excellent
10.41%
Good
11.65%
Good
0.47%
65.3/100
4538
₹126430.62
58.4
Average
26.52%
Excellent
27.05%
Excellent
0.3
Excellent
13.84%
Good
7.72%
Good
0.86%
Cipla Ltd...
CIPLA500087
59/100
1418
₹123059.76
22.6
Average
17.77%
Good
22.72%
Excellent
0.0
Excellent
28.68%
Excellent
9.97%
Good
0.85%
59.2/100
1319
₹105224.96
18.2
Average
17.96%
Good
22.69%
Excellent
0.2
Excellent
22.28%
Excellent
13.26%
Good
0.63%
Lupin Ltd...
LUPIN500257
66.7/100
2276
₹95148.15
22.0
Average
20.62%
Excellent
21.30%
Excellent
0.3
Excellent
54.88%
Excellent
8.11%
Good
0.58%
68.7/100
957
₹94253.78
18.7
Average
21.21%
Excellent
24.31%
Excellent
0.4
Excellent
25.92%
Excellent
10.27%
Good
1.17%
50.6/100
2420
₹92012.53
52.6
Average
14.68%
Average
15.98%
Good
0.6
Good
11.73%
Good
15.79%
Excellent
0.04%
28.8/100
1436
₹70798.69
20.7
Average
11.08%
Average
14.18%
Average
0.2
Excellent
3.87%
Average
6.55%
Good
0.33%
59.5/100
5452
₹67075.29
28.5
Average
19.39%
Good
20.38%
Excellent
0.2
Excellent
13.93%
Good
9.21%
Good
0.80%

IOL Chemicals and Pharmaceuticals Ltd PE Ratio History

Historical price-to-earnings ratio for IOLCP — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20253.44₹82.2623.9x
FY 20244.58₹81.5117.8x
FY 20234.74₹92.6619.5x
FY 20225.71₹74.6513.1x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

IOL Chemicals and Pharmaceuticals Ltd Dividend History

Annual cash dividends paid by IOLCP — dividend yield 0.89%

Financial YearDividends Paid (₹ Cr)
FY 202523.48 Cr
FY 202429.35 Cr
FY 202323.50 Cr
FY 202235.22 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

IOL Chemicals and Pharmaceuticals Ltd Quarterly Performance

Latest quarterly metrics for IOLCP — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

7.95%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

56.66%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

1.88%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-22.48%

Compounded annual net profit growth over 5 years

IOL Chemicals and Pharmaceuticals Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for IOLCP — calculated from daily price history

77RSI 14
Overbought — RSI 77

Momentum is strong — price may be stretched. Watch for pullbacks.

SMA 50
92
▲ Price above SMA 50 — Short-term bullish
SMA 200
90
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
5012K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

IOL Chemicals and Pharmaceuticals Ltd Financial Statements

Annual income statement, balance sheet and cash flow for IOL Chemicals and Pharmaceuticals Ltd (IOLCP) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for IOL Chemicals and Pharmaceuticals Ltd

About IOLCP (IOL Chemicals and Pharmaceuticals Ltd)

IOL Chemicals and Pharmaceuticals Ltd is a prominent player in the pharmaceutical and chemical manufacturing landscape, distinguished by its integrated operations and diverse produ...ct portfolio. The company stands as a reliable supplier, catering to a wide range of industries both domestically and internationally. Their commitment to quality and innovation is reflected in their advanced manufacturing facilities and stringent quality control processes, ensuring consistent product excellence and adherence to global standards. IOLCP prioritizes sustainable practices and environmental responsibility, striving to minimize its ecological footprint through efficient resource management and waste reduction initiatives. This dedication to both operational efficiency and environmental stewardship positions IOLCP as a trusted and forward-thinking partner in the chemical and pharmaceutical sectors. IOLCP's operational structure is strategically divided into two key segments: Chemicals and Pharmaceuticals. The Chemical segment manufactures a range of essential industrial chemicals, including ethyl acetate, renowned for its use in flexible packaging and food processing, and acetyl chloride, critical in pharmaceutical synthesis. Other key products like iso butyl benzene, mono chloro acetic acid, and acetic anhydride serve vital roles in textiles, paints, pesticides, and various chemical intermediates. The Pharmaceutical segment is dedicated to producing high-quality active pharmaceutical ingredients (APIs) that form the foundation for numerous life-saving medications. The company continually invests in research and development to expand its product offerings and meet the evolving needs of its diverse customer base. The company's global reach extends across numerous countries, solidifying its position as a significant exporter and contributing to India's reputation as a pharmaceutical and chemical hub. IOLCP’s success is built on a foundation of customer centricity, providing customized solutions and responsive support to meet specific client requirements. The company's adherence to ethical business practices and transparent operations has fostered long-term relationships with customers and stakeholders alike. IOLCP consistently aims to enhance its capabilities, optimize its supply chain, and strengthen its market presence, thereby driving sustainable growth and delivering value to its shareholders. Its enduring commitment to innovation and excellence ensures its continued success in the competitive pharmaceutical and chemical markets.

Company Details

Symbol:IOLCP
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Varinder Gupta
MD & Whole Time Director
Mr. Vikas Gupta
Joint Managing Director & Executive Director
Mr. Pardeep Kumar Khanna
Chief Financial Officer

Corporate Events

Recent
Ex-Dividend Date

IOLCP Share Price: Frequently Asked Questions

What is the current share price of IOL Chemicals and Pharmaceuticals Ltd?

IOL Chemicals and Pharmaceuticals Ltd (IOLCP) trades at ₹125.10 on NSE and BSE. Market cap ₹2.64K (Cr). Educational data only.

What is the P/E ratio of IOL Chemicals and Pharmaceuticals Ltd?

IOL Chemicals and Pharmaceuticals Ltd has a P/E of 22.72x vs industry average 31.77x.

What is the Bull Run score for IOL Chemicals and Pharmaceuticals Ltd?

IOL Chemicals and Pharmaceuticals Ltd has a Bull Run score of 42.1/100 based on 25+ financial parameters.

Does IOL Chemicals and Pharmaceuticals Ltd pay dividends?

IOL Chemicals and Pharmaceuticals Ltd has a dividend yield of 0.89%. Past dividends don't guarantee future payments.

What is the ROE of IOL Chemicals and Pharmaceuticals Ltd?

IOL Chemicals and Pharmaceuticals Ltd has ROE of 6.13%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of IOL Chemicals and Pharmaceuticals Ltd?

IOL Chemicals and Pharmaceuticals Ltd has debt-to-equity of 0.09.

Is IOL Chemicals and Pharmaceuticals Ltd a good investment?

Bull Run gives IOL Chemicals and Pharmaceuticals Ltd a score of 42.1/100. This is not investment advice — consult a SEBI-registered advisor.